Skip to main content
. 2022 May 27;12:814895. doi: 10.3389/fonc.2022.814895

Figure 1.

Figure 1

Consort diagram of the nimotuzumab plus cisplatin-chemoradiation arm versus cisplatin-chemoradiation arm showing the patient selection.